How much funding has Prolaio raised?

Prolaio has disclosed $25.5M raised across 1 round.

Where is Prolaio headquartered?

Prolaio is headquartered in Scottsdale, US.

Prolaio

Scottsdale, US · Founded 2021 · Delaware corporation

Find your way into Prolaio

Paths you didn't know you had: your email and LinkedIn already hold routes to the Prolaio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Prolaio develops continuous, predictive heart data monitoring using high-density data capture and advanced analytics to support cardiovascular therapy development and patient care. It serves patients and drug developers in cardiology, aiming to replace episodic monitoring with real-world data and AI-based tools.

AI & Machine Learning Digital Health Healthtech Medical Devices

Founders & leadership

Konstantin PoukalovNamed on SEC filing

Jay EdelbergNamed on SEC filing

Tassos GianakakosCo-founder, Chief Executive Officer and Chair

Reported raises · per SEC filings

Form D private placements

$25.5M disclosed across 1 round · 2023

▶$25.5MraisedJul 2023 · 3 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Konstantin PoukalovDirector
Jay EdelbergExecutive Officer, Director
Tassos GianakakosExecutive Officer, Director

Offering amount: $25.5M
Amount sold: $25.5M
First sale: Jul 2023
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies working in the same space as Prolaio.

Frequently asked questions

What does Prolaio do?: Prolaio develops continuous, predictive heart data monitoring using high-density data capture and advanced analytics to support cardiovascular therapy development and patient care. It serves patients and drug developers in cardiology, aiming to replace episodic monitoring with real-world data and AI-based tools.
How much funding has Prolaio raised?: Prolaio has disclosed $25.5M raised across 1 round.
Where is Prolaio headquartered?: Prolaio is headquartered in Scottsdale, US.